(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Lung Cancer
This study is to determine whether an investigational medication
is an effective and safe treatment for patients with recurrent small cell
lung cancer. Men and women 18 years and above who have confirmed
recurrent small cell lung cancer may be eligible to participate. Research
sites located throughout the United States and the United Kingdom.
More Information
Please see http://www.centerwatch.com/patient/studies/cat34.html.
-----
Obsessive-Compulsive Disorders
An open-label study of escitalopram (Lexapro) in the treatment
of obsessive-compulsive disorder (OCD). This study is for people aged 18-65
who currently suffer from OCD. No pregnant women may participate. Research
site located in Boston, Massachusetts.
More Information
Please see http://www.centerwatch.com/patient/studies/cat108.html.
-----
Prostate Cancer
A research study involving an experimental medication for the
treatment of prostate cancer. Men who are in generally good health and have
been diagnosed with prostate cancer may be eligible to participate. Research
site located in Staten Island, New York.
More Information
Please see http://www.centerwatch.com/patient/studies/cat36.html.
-----
Copyright 2003 CenterWatch. All rights reserved.
